Total Funding
22
42
Total FundingNon-equity Assistance raised
Growth Score
-5 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
81868
A precision molecular diagnostics start-up that develops PCR and NGS-based solutions for both human and animal applications
- Revata Utama: Founder, CEOPast Role: Nusantics, Co-Founder & CTO
About the Company
Nusantics is a precision molecular diagnostics startup from Indonesia; we develop PCR and Next Generation Sequencing-based solutions to improve healthcare outcomes in both human and animal applications. We offer 3 types of products; single pathogen molecular diagnostics, syndromic molecular diagnostics, and microbiome diagnostics (NGS)
